Baylor Genetics to Present Data at NSGC 2026
The company will share two poster presentations and host a lunch symposium at the 2026 NSGC Annual Conference in Baltimore.
Updated on Nov. 9, 2026 in Life Sciences
Baylor Genetics will present two poster presentations and host a lunch symposium at the 2026 NSGC Annual Conference in Baltimore, MD, scheduled for November 10-14, 2026. The posters cover genome and exome sequencing for children with hearing loss and immunodeficiency.
Why it matters
The presentations focus on the diagnostic and clinical utility of genome and exome sequencing in pediatric patients with specific conditions. The data is intended to inform genetic counseling and genomic testing practices across the care continuum.
The two posters address pediatric genome and exome sequencing for hearing loss (#GENT247) and immunodeficiency (#GENT246), with the company exhibiting at booth #1376. Specific results and sample sizes have not yet been released ahead of the presentations.
The players
Baylor Genetics
A Houston-based genetic testing laboratory headquartered in the Texas Medical Center that serves clients across all 50 states.
Christine Eng, MD
Chief Medical Officer and Chief Quality Officer at Baylor Genetics who is presenting at the symposium.
Sabrina Southwick, MS, CGC
A prenatal genetic counselor at Johns Hopkins who is presenting at the Baylor Genetics symposium.
The details
Baylor Genetics, headquartered in Houston's Texas Medical Center, will share data through poster sessions and a lunch symposium titled Reimagining Genomic Testing Across the Care Continuum. The symposium features Christine Eng, MD, the company's Chief Medical Officer and Chief Quality Officer, and Sabrina Southwick, MS, CGC, a prenatal genetic counselor at Johns Hopkins.
Timeline
November 10-14, 2026: 2026 NSGC Annual Conference in Baltimore, MD.
Wednesday, November 11, 2026, 12:15 p.m. EST: Baylor Genetics lunch symposium, room 314-317.
Health Landscape
The NSGC Annual Conference is the principal yearly forum where genetic counselors and clinicians review evolving diagnostic testing practices, including exome and genome sequencing. Baylor Genetics' presentations add pediatric hearing loss and immunodeficiency data to that ongoing discussion.
Patients and families whose children face hearing loss or immunodeficiency may gain clearer information on whether genome or exome sequencing can establish a diagnosis. Clinicians and genetic counselors can use the presented data to weigh testing options against the clinical needs of pediatric patients.
The takeaway
Genome and exome sequencing for children with hearing loss or immunodeficiency is the focus of these presentations. Families and clinicians interested in these topics can watch for the posters and symposium at the November conference.
What happens next
Baylor Genetics will present its two posters and lunch symposium at the 2026 NSGC Annual Conference on November 10-14, 2026, with the symposium scheduled for November 11 at 12:15 p.m. EST.
Further reading
For broader context on lab-based research, see Life Sciences coverage across Houston.
More information
Details on the company's presentations are available on the Baylor Genetics NSGC 2026 conference information page.
Source note: This article includes information reported by The Manila times.
